MGMT and glioblastoma: Another example, resistance to the alkylating chemotherapeutic agents, was significantly linked with the overexpression of the O6-methylguanine DNA methyltransferase (MGMT) repair enzyme, as glioblastoma patients with increased levels of MGMT showed poor treatment outcomes and higher mortality rates compared with the patients with reduced expression levels [70].